Loading company…
UNITY Biotechnology develops therapies that remove senescent cells to treat age-related diseases, including osteoarthritis.
Founded in 2009 in Brisbane, US, by Akeem Shinholster and Nathaniel David, UNITY Biotechnology develops biologic treatments that eliminate senescent cells implicated in degenerative conditions, including osteoarthritis and retinal diseases that cause vision loss. It raised USD 85 mn through an IPO in May 2018, its total funding to date. Anirvan Ghosh is CEO. In 2022 it reported revenue of USD 236,000 and EBITDA of USD -30,304,000.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in